Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 04:00PM ET
0.7200
Dollar change
-0.0016
Percentage change
-0.22
%
IndexRUT P/E- EPS (ttm)-0.32 Insider Own36.14% Shs Outstand153.04M Perf Week-1.36%
Market Cap116.59M Forward P/E- EPS next Y-0.21 Insider Trans-0.01% Shs Float103.40M Perf Month-7.43%
Income-36.16M PEG- EPS next Q-0.05 Inst Own39.65% Short Float5.82% Perf Quarter-35.71%
Sales34.53M P/S3.38 EPS this Y-237.50% Inst Trans4.92% Short Ratio7.52 Perf Half Y-38.46%
Book/sh0.39 P/B1.85 EPS next Y36.36% ROA-25.44% Short Interest6.02M Perf Year-57.65%
Cash/sh0.49 P/C1.46 EPS next 5Y- ROE-49.79% 52W Range0.60 - 1.76 Perf YTD4.44%
Dividend Est.- P/FCF- EPS past 5Y- ROI-52.39% 52W High-59.09% Beta0.59
Dividend TTM- Quick Ratio4.51 Sales past 5Y307.70% Gross Margin94.10% 52W Low19.98% ATR (14)0.08
Dividend Ex-Date- Current Ratio4.51 EPS Y/Y TTM-168.78% Oper. Margin-169.63% RSI (14)48.25 Volatility9.73% 10.11%
Employees64 Debt/Eq0.17 Sales Y/Y TTM-72.13% Profit Margin-104.71% Recom1.00 Target Price1.00
Option/ShortYes / Yes LT Debt/Eq0.14 EPS Q/Q-12.79% Payout0.00% Rel Volume1.10 Prev Close0.72
Sales Surprise- EPS Surprise- Sales Q/Q-68.37% EarningsAug 17 BMO Avg Volume800.70K Price0.72
SMA20-0.96% SMA50-1.17% SMA200-29.70% Trades Volume884,084 Change-0.22%
Date Action Analyst Rating Change Price Target Change
Aug-18-23Downgrade SVB Securities Outperform → Market Perform $1
Jun-14-22Reiterated Needham Buy $6 → $5
Jun-06-22Initiated SVB Leerink Outperform $7
Jun-15-21Initiated BTIG Research Buy $10
Jan-26-21Upgrade Mizuho Neutral → Buy $2.50 → $8
Oct-01-20Downgrade William Blair Outperform → Mkt Perform
Oct-01-20Downgrade Mizuho Buy → Neutral $2.50
Jun-12-20Downgrade Stifel Buy → Hold
Apr-28-20Initiated H.C. Wainwright Buy $8
Jan-29-20Initiated Cantor Fitzgerald Overweight $10
Feb-05-24 04:05PM
Jan-22-24 09:19AM
Jan-08-24 07:10AM
07:00AM
Nov-13-23 08:05AM
04:03PM Loading…
Oct-31-23 04:03PM
Aug-24-23 06:21AM
Aug-17-23 10:20PM
08:15AM
07:00AM
Jul-14-23 07:08AM
Jul-13-23 03:00PM
Jun-03-23 08:20AM
May-31-23 07:00AM
May-09-23 06:06AM
08:45AM Loading…
May-04-23 08:45AM
07:30AM
Apr-28-23 04:05PM
Apr-18-23 06:11AM
Mar-27-23 07:07AM
Mar-21-23 11:48AM
03:30AM
Mar-06-23 05:59AM
Mar-03-23 01:24AM
Mar-02-23 09:25AM
07:30AM
Feb-23-23 08:00AM
Feb-07-23 01:51PM
08:00AM
Jan-31-23 01:15PM
11:33AM Loading…
Jan-17-23 11:33AM
Jan-12-23 05:39AM
Jan-09-23 08:00AM
07:30AM
Dec-21-22 10:29AM
Dec-14-22 08:00AM
Dec-01-22 05:43AM
Nov-28-22 08:00AM
Nov-09-22 06:36AM
Nov-07-22 08:00AM
Nov-03-22 09:15AM
08:00AM
Oct-27-22 08:00AM
Oct-18-22 06:13AM
Oct-11-22 08:00AM
Oct-10-22 06:10PM
Sep-29-22 08:00AM
Sep-12-22 08:00AM
Sep-06-22 08:00AM
Aug-30-22 06:21AM
Aug-29-22 05:08PM
Aug-12-22 09:30AM
Aug-09-22 10:25AM
Aug-06-22 08:25AM
Aug-04-22 09:05AM
07:30AM
Aug-01-22 08:00AM
Jul-28-22 12:00PM
08:00AM
Jul-19-22 09:19AM
Jul-14-22 09:03AM
Jul-12-22 07:49AM
Jul-06-22 08:00AM
Jun-29-22 07:00AM
Jun-20-22 07:43AM
Jun-14-22 08:59AM
Jun-13-22 07:30AM
Jun-10-22 03:26PM
Jun-06-22 02:47PM
May-19-22 06:00PM
May-17-22 08:00AM
May-10-22 03:23PM
May-05-22 08:45AM
07:30AM
May-02-22 04:30PM
Apr-28-22 08:00AM
Apr-06-22 06:56PM
Apr-04-22 08:00AM
Mar-10-22 09:25AM
08:00AM
Mar-09-22 08:45AM
Mar-03-22 08:00AM
Feb-09-22 08:00AM
Jan-11-22 11:48AM
11:21AM
Jan-10-22 07:00AM
Jan-05-22 08:00AM
Dec-29-21 08:00AM
Dec-12-21 07:05AM
Dec-02-21 06:00AM
Dec-01-21 08:00AM
Nov-25-21 10:56AM
Nov-24-21 04:15PM
Nov-14-21 08:53AM
Nov-11-21 08:00AM
Nov-09-21 09:15AM
08:00AM
Nov-08-21 08:12AM
Nov-05-21 08:00AM
Oct-28-21 03:05PM
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brunn CarstenPresident and CEOSep 25Sale1.062,9323,108783,081Sep 26 06:01 PM
TRABER PETER GChief Medical OfficerSep 25Sale1.06705747451,826Sep 26 06:00 PM